Involvement of the OTUB1-YAP1 axis in driving malignant behaviors of head and neck squamous cell carcinoma

書誌事項

タイトル
Involvement of the OTUB1-YAP1 axis in driving malignant behaviors of head and neck squamous cell carcinoma
タイトル別名
  • OTUB1-YAP1経路の頭頸部扁平上皮癌の悪性化への関与
著者
Jin, Shengjian
著者
Tsunematsu, Takaaki
著者
Horiguchi, Taigo
著者
Mouri, Yasuhiro
著者
Shao, Wenhua
著者
Miyoshi, Keiko
著者
Hagita, Hiroko
著者
Sarubo, Motoharu
著者
Fujiwara, Natsumi
著者
Qi, Guangying
著者
Ishimaru, Naozumi
著者
Kudo, Yasusei
学位授与大学
徳島大学
取得学位
博士(歯学)
学位授与番号
甲第3826号
学位授与年月日
2023-11-20

説明

収集根拠 : 博士論文(自動収集)
資料形態 : テキストデータ
コレクション : 国立国会図書館デジタルコレクション > デジタル化資料 > 博士論文
Background: Comprehending the molecular mechanisms underlying head and neck squamous cell carcinoma (HNSCC) is vital for the development of effective treatment strategies. Deubiquitinating enzymes (DUBs), which regulate ubiquitin-dependent pathways, are potential targets for cancer therapy because of their structural advantages. Here we aimed to identify a potential target for HNSCC treatment among DUBs.Methods: A screening process was conducted using RNA sequencing data and clinical information from HNSCC patients in the TCGA database. A panel of 88 DUBs was analyzed to identify those associated with poor prognosis. Subsequently, HNSCC cells were modified to overexpress specific DUBs, and their effects on cell proliferation and invasion were evaluated. In vivo experiments were performed to validate the findings.Results: In HNSCC patients, USP10, USP14, OTUB1, and STAMBP among the screened DUBs were associated with a poor prognosis. Among them, OTUB1 showed the most aggressive characteristics in both in vitro and in vivo experiments. Additionally, OTUB1 regulated the stability and nuclear localization of YAP1, a substrate involved in cell proliferation and invasion. Notably, OTUB1 expression exhibited a positive correlation with the HNSCC-YAP score in HNSCC cells.Conclusions: This study highlights the critical role of OTUB1 in HNSCC progression via modulating YAP1. Targeting the OTUB1-YAP1 axis holds promise as a potential therapeutic strategy for HNSCC treatment.

詳細情報 詳細情報について

問題の指摘

ページトップへ